...
【24h】

Leprosy of the Past and Today

机译:过去和今天的麻风病

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Despite enhanced disease control efforts, leprosy remains an important cause of disability in several countries. Being based on case detection, the exact prevalence of the disease is not easily estimated. Currently around 600,000 new cases are treated annually. Advances in immunology and molecular biology have led to a greater understanding of the disease and to hopes for improved diagnostic tests and vaccination strategies. The major advance, though, is the development of highly effective combination drug regimens which, provided all doses are taken, rarely fails to cure. The challenge to leprosy control services is to overcome the stigma associated with the disease so that patients present with minimal lesions and before disabilities have developed. Although it is hoped that leprosy as a serious public health problem will be eliminated within a few years, continuing care for those suffering from deformity and rejection by society will be required for several decades.
机译:尽管加强了疾病控制工作,麻风病仍是一些国家致残的重要原因。基于病例检测,不容易估计疾病的确切患病率。目前,每年约有60万新病例得到治疗。免疫学和分子生物学的进步导致人们对该疾病有了更深入的了解,并有望改善诊断测试和疫苗接种策略。但是,主要的进步是开发了高效的联合用药方案,只要采取所有剂量,很少治愈。麻风控制服务所面临的挑战是克服与疾病相关的污名,使患者呈现出最小的病变并且在残疾发展之前。尽管希望在几年之内消除麻风病这一严重的公共卫生问题,但数十年来仍需要继续照顾那些遭受畸形和社会排斥的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号